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Abstract
Background: Protein misfolding and subsequent aggregation are hallmarks of several human diseases. The cell has
a variety of mechanisms for coping with misfolded protein stress, including ubiquitin-mediated protein
degradation. In fact, the presence of ubiquitin at protein aggregates is a common feature of protein misfolding
diseases. Ubiquitin conjugating enzymes (UBCs) are part of the cascade of enzymes responsible for the regulated
attachment of ubiquitin to protein substrates. The specific UBC used during ubiquitination can determine the type
of polyubiquitin chain linkage, which in turn plays an important role in determining the fate of the ubiquitinated
protein. Thus, UBCs may serve an important role in the cellular response to misfolded proteins and the fate of
protein aggregates.
Results: The Q82 strain of C. elegans harbors a transgene encoding an aggregation prone tract of 82 glutamine
residues fused to green fluorescent protein (Q82::GFP) that is expressed in the body wall muscle. When measured
with time-lapse microscopy in young larvae, the initial formation of individual Q82::GFP aggregates occurs in
approximately 58 minutes. This process is largely unaffected by a mutation in the C. elegans E1 ubiquitin activating
enzyme. RNAi of ubc-22, a nematode homolog of E2-25K, resulted in higher pre-aggregation levels of Q82::GFP and
a faster initial aggregation rate relative to control. Knockdown of ubc-1 (RAD6 homolog), ubc-13, and uev-1 did not
affect the kinetics of initial aggregation. However, RNAi of ubc-13 decreases the rate of secondary growth of the
aggregate. This result is consistent with previous findings that aggregates in young adult worms are smaller after
ubc-13 RNAi. mCherry::ubiquitin becomes localized to Q82::GFP aggregates during the fourth larval (L4) stage of life,
a time point long after most aggregates have formed. FLIP and FRAP analysis indicate that mCherry::ubiquitin is
considerably more mobile than Q82::GFP within aggregates.
Conclusions: These data indicate that initial formation of Q82::GFP aggregates in C. elegans is not directly
dependent on ubiquitination, but is more likely a spontaneous process driven by biophysical properties in the
cytosol such as the concentration of the aggregating species. The effect of ubiquitination appears to be most
significant in later, secondary aggregate growth.
Background
A number of diseases are known as protein misfolding
disorders, or “conformational” diseases due to their
association with protein misfolding and aggregation [1].
The most well-known of these are neurodegenerative
diseases and include Alzheimer’s, Parkinson’s, and Hun-
tington’s disease. Other conformational diseases include
cystic fibrosis and the muscle-wasting disease inclusion
body myositis. The proteins underlying these diseases
vary in sequence and structure, and the exact cause of
the aberrant folding cannot always be attributed to spe-
cific mutations. However, these diseases are commonly
characterized histologically by the presence of insoluble
intracellular protein aggregates. These aggregates gener-
ally contain the misfolded species along with a variety of
other proteins. One common hallmark of aggregates in
conformational diseases is the presence of ubiquitin
[2-6]. While it is not entirely clear whether the ubiquitin
in aggregates has been conjugated to the misfolded
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as a free monomer, its presence indicates a potential
role for ubiquitin in the aggregation process or in the
cellular response to aggregation.
Ubiquitination is an important post-translational mod-
ification marked by regulated covalent attachment of the
8-kDa protein ubiquitin to specific cellular protein tar-
gets [7]. Through the action of the E1-E2-E3 series of
enzymes, a high degree of substrate specificity is
attained thus affording tight spatial and temporal con-
trol of a variety of cellular processes. Membrane protein
transport [8], DNA damage repair [9], and histone regu-
lation [10] are all known to be directly regulated by ubi-
quitination. The most well known fate of ubiquitinated
p r o t e i ns u b s t r a t e si sd e g radation by the 26 S protea-
some. Targeting of substrate proteins to the proteasome
for degradation is mediated by the sequential attach-
ment of ubiquitin to form a polyubiquitin chain of at
least 4 ubiquitins, linked serially via isopeptide bonds
between the C-terminal glycine of one ubiquitin to the
ε-amino group of lysine 48 (K48) on the next [11].
Thus, the ubiquitin-proteasome system allows for speci-
fic degradation of protein targets and regulates cellular
processes by controlling the half-life of proteins in path-
ways such as the cell cycle [12]. In addition to regulating
cellular pathways, the ubiquitin-proteasome system is
also important in the degradation of misfolded or
damaged proteins, as part of protein quality control
(PQC) system. During misfolded protein stress, cellular
levels of ubiquitinated proteins increase significantly
[13]. Polyubiquitin chains formed by attachment of suc-
cessive ubiquitins through lysine 63 (K63) have been
found to mediate endocytosis [14], NFB function [15],
and trafficking of proteins to form perinuclear aggre-
gates known as aggresomes [16].
T h eE 1e n z y m ef o ru b i q u i t i n a t i o ni nC. elegans is
UBA-1. There is a single E1 for ubiquitin in C. elegans
and 26 E2s, the UBCs or UEVs [17,18]. A UBC accepts
ubiquitin from the E1, then directly transfers ubiquitin
to either the target substrate or to a cysteine residue of
a HECT domain E3. The E3 ubiquitin ligases are impor-
tant in substrate recognition. A single UBC can interact
with multiple E3s, and a single E3 can likely interact
w i t hm u l t i p l eU B C s .S p e c i f i cU B C sc a np l a yar o l ei n
determining the type of polyubiquitin chain formed on a
target substrate. For example, the Saccharomyces cerevi-
siae Ubc13p, in conjunction with Mms2p, catalyzes the
formation of K63-linked polyubiquitin chains [19], while
yeast Ubc1p catalyzes the formation of K48-linked
chains [20]. In addition, it appears that some chain-
extending UBCs cannot initiate polyubiquitination with-
out a previously conjugated acceptor ubiquitin [21].
Thus, an E3’s choice of interacting UBC can determine
the type of ubiquitination on the target, and its fate.
Proteins containing pathogenic polyglutamine expan-
sions, such as those observed in Huntington’s disease,
spinal bulbar muscular atrophy, and spinocerebellar
ataxia are particularly prone to aggregation and forma-
tion of ubiquitin-positive inclusions [22]. In vivo and in
vitro studies on the misfolding and aggregation of poly-
glutamine proteins have suggested a model in which
one or more soluble, metastable polyglutamine mono-
mers form a critical nucleus that is prone to oligomeri-
sations. An autocatalytic feedback loop involving the
misfolded monomers and oligomers promotes the tran-
sition of more monomers to the aggregation-prone con-
formation, accelerating the oligomer formation [23].
There is ongoing debate regarding the toxicity of
intracellular protein aggregates. Some evidence suggests
that the aggregates may sequester non-pathological cel-
lular proteins and may lead to loss-of-function pheno-
types for these proteins [24,25]. Proteins containing
polyglutamine tracts are particularly prone to co-aggre-
gation with other polyglutamine proteins [26]. In cell
culture models, expression of protein aggregates can
cause impairment of the ubiquitin-proteasome system
[27,28]. Later studies supported a model where the early
or intermediate forms of protein aggregates caused pro-
teasomal impairment, which was relieved by inclusion
body formation [29-31]. Still, other evidence suggests
that the large aggregates may be neutral or cytoprotec-
tive for the cell [32-36].
The formation of aggregates may aid the cell’s proteo-
lytic mechanisms in ridding the cell of the misfolded
protein. Chen and associates found that some nuclear
inclusions co-localize with areas of proteasomal proteo-
lysis [37]. Localization of proteasomal machinery has
been shown with polyglutamine-containing aggregates in
a p62-dependent manner [38]. Cytosolic aggregates may
be subject to degradation by autophagy [39] as well as
by the ubiquitin-proteasome system [40].
In some cases, it appears that the cell actively trans-
ports misfolded proteins into juxtanuclear, pericentrio-
lar, vimentin-caged inclusions termed “aggresomes”,a
process that involves ubiquitination [41]. This may
reflect an adaptation by cells that serves to accumulate
damaged proteins in a single location, allowing for more
efficient degradation by autophagy. The transport to
aggresomes along microtubules is facilitated by K63-
linked polyubiquitin chains. p62 may also be involved in
directing aggregates to non-proteasomal protein degra-
dation by autophagy [38]. K63-polyubiquitinated pro-
teins are transported by dynein-dynactin complexes via
the adapter histone deacetylase 6 (HDAC6) [42]. Forma-
tion of aggresomes may be protective, as experiments in
which formation of these structures is inhibited results
in increased cytotoxicity to cultured cells [43]. In addi-
tion, aggresomes appear to protect cells expressing the
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and synphilin-1 [44].
Protein aggregation appears to be associated with non-
disease biology as well. A recent study found that gen-
eral protein insolubility increases with age in C. elegans
[45]. In addition, protein aggregation may play an
important role in the immune system. Dendritic cell
aggresome-like-induced structures (DALIS), which con-
tain ubiquitinated proteins, have been hypothesized to
be involved in temporary storage of antigens during
maturation of dendritic cells [46].
It has been beneficial to develop animal, cell, and in
vitro systems for studying protein aggregation. Mori-
moto et al., have developed a transgenic strain of C. ele-
gans (henceforth referred to as Q82) that expresses an
aggregation prone stretch of 82 glutamines fused to
GFP (Q82::GFP) in the body wall muscle cells [47]. The
polyglutamine reporter protein aggregates into distinct
puncta that recapitulate many of the features of disease
aggregates, including insolubility [47], interactions with
chaperones [48], and positive staining for ubiquitin [49].
In a previous RNAi screen, our lab demonstrated that
RNAi knockdown of specific UBCs affects the size,
number, and ubiquitin immunoreactivity of these aggre-
gates in the Q82 strain [17]. Specifically, RNAi of ubc-1,
ubc-13, and uev-1 resulted in significantly smaller aggre-
gates that did not stain positively for ubiquitin or pro-
teasome. RNAi of ubc-2 or ubc-22 resulted in larger
aggregates that were fewer in number. Similar effects
were seen after RNAi of human homologs of these
genes in cultured HEK293 cells [17].
The current study expands upon those results by
examining dynamics of aggregate formation in vivo.
Time-lapse fluorescence microscopy of Q82::GFP reveals
a biphasic nature to polyglutamine aggregation in C. ele-
gans. Initial formation of microscopically visible aggre-
gates occurs rapidly and is largely unaffected by knock
down of UBCs. RNAi of ubc-22 resulted in higher levels
of initial fluorescence. RNAi of ubc-13 impedes growth
of aggregates during the secondary growth phase.
Furthermore, we examined the dynamics of aggregate
ubiquitination by use of a fluorescent mCherry::ubiqui-
tin fusion protein and found that localization of this
protein to the Q82::GFP aggregates is secondary to
initial formation.
Results
Initial Q82::GFP aggregate formation occurs rapidly in L1
and L2-stage worms
T h et r a n s g e n i cQ 8 2s t r a i no fC. elegans expresses a
fusion protein that consists of 82 glutamine residues
fused to GFP, under control of the unc-54 promoter for
expression in the body wall muscle cells. Aggregates
form throughout the animal’s development to adulthood
[47]. We have employed this model to examine the
early formation of aggregates, and the role of ubiquitina-
tion in this process. L1- and L2-stage worms readily
form distinct puncta of Q82::GFP that appear concur-
rently with the disappearance of diffuse, putatively solu-
ble fluorescent material (Additional files 1 and 2 Figure:
Videos 1 and 2). This process of initial aggregate forma-
tion occurs rapidly, with the time for aggregation to
occur (defined as the time taken for total fluorescence
to increase from 10% to 90% of maximum) being 58.1 ±
21.5 minutes. Initial formation is represented by a sig-
moidal curve (Figure 1) when plotted as a function of
time. This is followed by secondary growth, in which
fluorescence increases at a slower rate. Aggregates form-
ing during time-lapse observation are similar in size to
those that were formed prior to microscopic observa-
tion. They consists of largely immobile Q82::GFP, as
they do not show fluorescence recovery after photo-
bleaching (G.S., data not shown).
In order to examine the potential role of ubiquitination
in the aggregation process, the Q82::GFP transgene was
crossed into a strain harboring a temperature sensitive
mutation in the uba-1 gene which is the single gene
encoding the ubiquitin E1 activating enzyme in C. ele-
gans. It has previously been shown via immunoblots
with anti-ubiquitin antibodies that overall ubiquitination
is dramatically reduced (> 90% reduction in ubiquitin
conjugates) under nonpermissive conditions (25°C) in
this mutant [50]. Figure 1 shows that in the time-lapse
assay, under nonpermissive conditions, reduction of
UBA-1 activity does not change the kinetics of single
formation events, as it does not significantly affect the
sigmoidal shape of the curve, the maximum rate of for-
mation, or the time taken for an aggregate to form. This
result suggests that the process of initial aggregate for-
mation may not be directly dependent on ubiquitination.
RNAi knockdown of UBCs has limited effect on the initial
aggregate growth phase
We have previously shown that RNAi knockdown of
specific UBCs can affect the size and number of aggre-
gates in worms at an age of 48 hours [17]. Specifically,
the most dramatic phenotypes were seen with ubc-1, -2,
-13, -22,a n duev-1. Therefore, these UBCs were chosen
for further analysis. For RNAi-mediated knockdown, the
identical RNAi feeding strains and protocols were used
that have been shown to reduce RNA to barely detect-
able levels [17]. Time-lap s em i c r o s c o p yw a su s e dt o
observe initial formation of aggregates in UBC knock
down worms. RNAi treatment was started in L2 worms,
and the L1 progeny of those worms were used for time-
lapse imaging. Fluorescence measurements of time-lapse
image series were made by recording the total intensity
of all pixels over time in a square region framing the
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tiple experiments, aggregation data were pooled by
treatment group, aligned for the coincidence of aggre-
gate formation, averaged at each time point, and plotted
to form composite curves (Figure 2). Notably, RNAi of
ubc-22,a n d ,t oal e s s e re x t e n t ,uev-1,r e s u l t e di na n
increase in initial levels of Q82::GFP, and an increase in
the rate of initial aggregate formation. To compare the
effects of the RNAi treatments on the rate of aggrega-
tion, a linear regression was performed on composite
curves at the period of initial rapid aggregation (minutes
5 8 - 6 2 )T h e s ed a t aa r es h o w ni nT a b l e1 .T h et a b l e
shows that almost all UBCs had an effect on initial
fluorescence levels. This may be due to a general disrup-
tion in the UPS by disruption of key components in that
pathway. ubc-13 w a st h eo n l yU B Ct os h o wn os i g n i f i -
cant effect on initial fluorescence level. In general,
higher initial levels of Q82::GFP are associated with
higher rates of aggregation. This correlation suggests
that once an aggregate is initially seeded, its formation
is largely diffusion-limited and dependent on concentra-
tion, rather than active cellular pathways.
RNAi knockdown of UBCs influences the secondary
aggregate growth phase
In the C. elegans Q82 model, aggregates in adult
worms are much larger than those seen in young lar-
vae. The data Figures 1 and 2 show that initially aggre-
gates form quickly, but that after initial formation,
aggregates continue to grow at a slower rate. Since
RNAi of UBCs affects aggregate size, we wanted to
investigate whether the UBCs might affect this second-
ary growth phase. Thus, from the same population of
worms in which we observed aggregate formation, we
recorded the growth of aggregates that had formed
prior to observation under the microscope (Figure 3).
Table 2 summarizes the growth rates of these aggre-
gates, as determined by a linear regression performed
on the data from Figure 3. In this case initial fluores-
cence level indicates the level of fluorescence in the
existing aggregate at the time of observation during
the L1 larval period. Initial fluorescence of aggregates
was higher in worms subjected to RNAi of ubc-22,
consistent with our previous findings [17]. In addition,
ubc-22 and ubc-1 RNAi aggregates grew at rates faster
Figure 1 Aggregation profile of Q82::GFP protein in C. elegans. C. elegans larvae expressing a Q82:GFP transgene in a wild type (black
diamonds) or in a uba-1 mutant (red squares) were imaged using a microscope with a 10X objective lens at a rate of 1 frame per minute. The
sum of the pixel intensity in a square region of the image sequence in which an aggregate formed was measured over time. Plots of individual
formation events were aligned along the time axis so that the frame at which the aggregation rate is highest occurs at 60 minutes. For each
individual aggregate formation, the fraction of the peak intensity was calculated at each time point. This chart shows the mean (± SEM)
fractional aggregate intensity at each time point for a total of 58 aggregate formations in 5 different time-lapse experiments for the Q82 strain
in the wild type background and 30 aggregate formations in 3 experiments for the Q82 in the uba-1(ts) background.
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ted with ubc-13 and uev-1 RNAi showed smaller
aggregates, consistent with results from our previous
study [17]. In addition, secondary growth was markedly
reduced upon RNAi of ubc-13 (Table 2). Since homo-
logs of ubc-13 and uev-1 are known to dimerize and to
catalyze the formation of K63-linked polyubiquitin
chains [9,19], it is possible that the reduced secondary
growth rate may be related to reduced levels of K63
ubiquitination.
Aggregates of Q82::GFP contain both K48- and K63-linked
polyubiquitin chains
Q82::GFP aggregates in the Q82 strain stain positive for
ubiquitin using a pan-ubiquitin primary antibody, simi-
lar to intracellular aggregates in many diseases [17].
Since the linkage type of a polyubiquitin chain attached
to a substrate is important in determining that protein’s
fate, examining the types of polyubiquitin chains present
i nt h ea g g r e g a t e sm a yp r o v i d ec l u e sa st ot h er o l eo f
ubiquitin in aggregate formation. Using antibodies speci-
fic to K48- or K63-linked polyubiquitin chains in an
immunofluorescence assay, we found that the Q82::GFP
aggregates in adult worms stain positive for both linkage
types (Figure 4). Both large, spherical aggregates and the
smaller, more granular aggregates appear to contain
both polyubiquitin chain types. Specificity of the antibo-
dies was supported by the observation that only the K48
antibody stains interphase nuclei while the K63 antibody
Figure 2 RNAi knockdown of UBCs affects the cellular level and aggregation rate of Q82::GFP fusion protein. C. elegans expressing a
Q82:GFP transgene were fed bacterial clones expressing dsRNA against the indicated genes or the empty pL4440 vector as a control, beginning
at the L2 stage. The progeny of these worms were imaged at a rate of 1 frame per minute. Pixel intensity in a square region of the image
sequence in which an aggregate formed was measured over time. Plots of individual formation events were aligned along the time axis so that
the frame at which the aggregation rate is highest occurs at 60 minutes. This chart shows the mean (± SEM) aggregate intensity at each time
point for each RNAi treatment. At least 50 aggregates were analyzed for each RNAi treatment. See Table 1 for calculation of aggregation rates.
Table 1 Initial fluorescence levels and aggregation rates
of Q82::GFP fusion protein
RNAi
treatment
Initial fluorescence level
prior to aggregation
(± SEM)
Aggregation rate of initial
formation (change in pixel
intensity minutes
-1)
pL4440
(empty
vector)
2712 ± 452 208.1
ubc-1 3335 ± 394 286.2
ubc-13 2827 ± 347 177.9
ubc-22 9349 ± 1124 344.9
uev-1 4847 ± 450 255.8
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data not shown).
Higher levels of ubiquitin colocalization are seen in L4
stage worms
A strain expressing mCherry::ubiquitin with Q82::GFP in
muscle cells (hereby referred to as Q82 + Ub) was used
to assess the dynamics of ubiquitin localization to aggre-
gates. A time course of mCherry::ubiquitin colocaliza-
tion was performed, in which worms were imaged every
12 hours and line profile measurements of individual
aggregates were taken to evaluate mCherry::ubiquitin
colocalization to Q82::GFP aggregates. Our results show
a spike in mCherry::ubiquitin colocalization in aggre-
gates at 36 hours (Figure 5C, D). In the same experi-
ment, groups exposed to RNAi of ubc-1 or ubc-22 show
reduced colocalization of mCherry::ubiquitin to the
polyglutamine aggregates (Figure 5D) at 36 hours.
The results indicate that ubiquitin localization to poly-
glutamine aggregates varies with developmental stage.
This finding is consistent with other reports suggesting
that the protein quality control pathways are not con-
stant throughout all periods of the life cycle. Interest-
ingly, the ratio of mCherry to GFP fluorescence seems
to decrease from 36 hours to 48 hours (Figure 5D). As
Q82::GFP aggregates increase in size during this time,
the decrease in mCherry::ubiquitin colocalization may
Figure 3 RNAi knockdown of UBCs alters the secondary growth of aggregates. C. elegans expressing a Q82::GFP transgene were fed
bacterial clones expressing dsRNA against the indicated genes or the empty pL4440 vector as a control, beginning at the L2 stage. The progeny
of these worms, belonging to the same population as the worms analyzed in Figure 2, were imaged using a microscope with a 10X objective
lens at a rate of 1 frame per minute. Aggregates that had formed prior to mounting on the slide were located using the automatic object
tracking feature of Image Pro Plus 6.1, which uses an intensity threshold to define the borders of the aggregates. The sum pixel intensity within
each automatically defined region was measured over time, omitting objects that formed during the observation period. The Y axis represents
the mean pixel intensity for all aggregates, plotted by gene. At least 50 aggregates were analyzed for each RNAi treatment. See Table 2 for
calculation of aggregation rates.
Table 2 Initial fluorescence levels and growth rates of
pre-formed aggregates
RNAi
treatment
Initial
fluorescence
level
Growth rate of pre-formed aggregates
(change in pixel intensity · minutes
-1)
pL4440
(empty
vector)
11761 ± 1131 17.52
ubc-1 12224 ± 1078 21.17
ubc-13 6781 ± 510 8.95
ubc-22 12546 ± 1287 19.19
uev-1 9927 ± 706 17.40
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(DUBs).
Photobleaching experiments reveal mobility of mCherry::
ubiquitin within Q82::GFP aggregates
Ubiquitin within aggregates may be attached to the pri-
mary aggregating protein, attached to other proteins
that coaggregate, or associated as a free monomer. The
mobility of the protein may provide insights into its
conjugation state. FRAP and FLIP experiments were
performed in order to examine the mobility of
mCherry::ubiquitin within the aggregates of Q82::GFP.
In the FRAP experiments, mCherry or GFP was
bleached within a region of the Q82::GFP aggregates in
adult worms and recovery was observed (Figure 6A, B).
Q82::GFP showed a slight recovery (Figure 6C) with a
mobile fraction of 23.3 ± 9.2. The mCherry::ubiquitin
fusion protein showed a higher degree of recovery, with
a mobile fraction of 70.8 ± 17.0. This result indicates
that while the polyglutamine protein, Q82::GFP, is
highly immobile within aggregates, ubiquitin shows a
greater rate of diffusion. The slow, continued increase in
mCherry recovery after the initial rapid recovery may
indicate the continued accumulation into aggregates of
mCherry::ubiquitin or substrates to which it is attached.
To further investigate the mobility of mCherry::ubiqui-
tin within Q82::GFP aggregates, fluorescence loss in
photobleaching (FLIP) was used. mCherry was continu-
ously bleached in a region either within the Q82::GFP
aggregate or in the cytoplasm of a cell expressing the
two fusion proteins. Loss of fluorescence in either a
separate region within the aggregate or in the cytoplasm
was monitored to examine mobility of the fluorescence
material (Figure 7A, B). Directing bleach pulses to either
Figure 4 Q82::GFP aggregates contain both K48- and K63-linked polyubiquitin chains. Synchronized adult worms were fixed and probed
with antibodies specific for K48 or K63 polyubiquitin chains. Secondary antibody was conjugated to TRITC (A, D, and G). Aggregates were
visualized via GFP fluorescence (B, E, H). Control samples (G) received the same treatment, without primary antibody. Merged images (C, F)
show colocalization of K48- or K63-linked polyubiquitin chains to aggregates, but not when the primary antibody is omitted (I).
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loss of fluorescence within the aggregate, indicating
mCherry::ubiquitin is sequestered within aggregates.
Bleaching within the cytoplasm reduced cytoplasmic
mCherry fluorescence, indicating the effectiveness of the
bleaching protocol and the mobility of mCherry::ubiqui-
tin within the cytoplasm (Figure 7C). These results sup-
port the notion that the mCherry::ubiquitin is
sequestered within the Q82::GFP aggregates, but is not
itself in an aggregated, immobile configuration.
Discussion
The presence of ubiquitin within protein aggregates is a
common feature in multiple diseases. In addition, many
of these diseases are age-related and may be associated
with impairment of protein quality control. Thus, it is
important to investigate the role that the ubiquitination
machinery plays in the process of aggregation. In this
study we examined the early formation of intracellular
polyglutamine aggregates, and found that ubiquitin con-
jugating enzymes do not play direct roles in initial
Figure 5 mCherry::ubiquitin colocalization to Q82::GFP aggregates. Worms co-expressing an mCherry::ubiquitin with Q82::GFP were exposed
to RNAi of ubc-22, ubc-1, or pL4440 control. A typical control aggregate is shown in (A) with a 10.16-micron line (45 pixels) measuring a cross-
section of fluorescence intensity. Data for this line profile is shown in (B). (C) Averaged line profile data for mCherry::ubiquitin fluorescence of
Q82::GFP aggregates at multiple time points. Higher levels of colocalization of mCherry::ubiqutin occur at an age of 36 hours. Peaks represent
fluorescence values in the aggregates while the peripheral points represent intracellular fluorescence. Values are the mean (± SEM) of all values
at that distance coordinate for aggregates at the given time point. All values have been normalized with respect to exposure time and
background levels of fluorescence. (D) Time course of mCherry::ubiquitin colocalization to Q82::GFP aggregates shows the spike in ubiquitin
colocalization at 36 hours, which is diminished by RNAi of ubc-1 or ubc-22. Data shown are the mean (± SEM) ratio of mCherry fluorescence to
GFP fluorescence from line profile measurements of composite images for multiple aggregates at each time point.
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substrates that are recruited to aggregates later.
Initial Q82::GFP aggregation occurs rapidly and is not
directly dependent on ubiquitination
Initial formation of Q82::GFP aggregates in C. elegans
muscle cells completes in approximately 1 hour. This
seems to be a rapid process, when considered in the
context of the slow, age associated onset of many
polyglutamine diseases. Aggregation rate was correlated
with Q82::GFP concentration immediately prior to
aggregate formation. A dependence of aggregation rate
on concentration is consistent with a model in which
the initial aggregation is a spontaneous, entropy-driven
process that is dependent on biophysical parameters
such as temperature and diffusion coefficient. Interest-
ingly, the aggregation curves for Q82::GFP are sigmoi-
dal, which is suggestive of a model of nucleation
Figure 6 FRAP analysis of mCherry::ubiquitin and Q82::GFP in polyglutamine aggregates reveals differential mobility of ubiquitin and
polyglutamine proteins within aggregates. Worms co-expressing an mCherry::ubiquitin fusion protein with Q82::GFP were subjected to FRAP
using a confocal laser scanning microscope system. Fluorescence intensity is indicated by a heat map of either Q82::GFP (A) or mCherry::
ubiquitin (B). Red or yellow rectangles indicate regions to where bleaching was directed. White rectangles indicate regions that were used to
control for acquisition photobleaching. Measurements of fluorescence recovery were taken every 0.1 s for 3 minutes. Quantitative analysis (C)o f
fluorescence recovery in bleached regions indicates higher overall mobility of mCherry::ubiquitin fusion protein when compared to Q82::GFP
protein. Data plotted are the mean ± SEM.
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ments lacking ubiquitination machinery produced aggre-
gation curves that fit a sigmoidal curve [51]. It should
be noted that the standard fluorescence microscopy
techniques used in this study are unable to detect the
formation of smaller, subresolution Q82::GFP oligomers
and protofibrils. Such smaller species may be forming
during the “lag time” prior to rapid aggregation, as seen
in vitro [52].
The observation that formation time does not change
significantly in worms in which ubiquitination has been
impaired due to a temperature sensitive mutation in
uba-1 further suggests that ubiquitination is not
required for initial aggregation in this model. In support
Figure 7 FLIP analysis of mCherry::ubiquitin and Q82::GFP. Worms co-expressing an mCherry::ubiquitin fusion protein with Q82::GFP were
subjected to FLIP analysis of the mCherry::ubiquitin protein to study mobility of ubiquitin. Fluorescence intensity is indicated by a heat map of
mCherry::ubiquitin prior to bleaching and at various times after commencement of repeated bleach pulses. Red squares indicate regions where
bleach pulses were directed, black and white squares indicate regions that were quantitatively analyzed for fluorescence loss, and yellow squares
indicate regions in non-bleached cells that were used to control for acquisition photobleaching. Separate experiments were carried out in which
bleaching was directed to the cytoplasm (A) or the aggregate of Q82::GFP (B). A quantitative analysis (C) was carried out to analyze fluorescence
loss over time. Results indicate no loss of mCherry fluorescence in aggregates when bleaching was directed to either a separate region within
the aggregate itself (blue diamonds) or an area in the cytoplasm. The loss of fluorescence in the cytoplasm when a region within the cytoplasm
was bleached indicates the effectiveness of the bleaching protocol (red squares), while the limited loss of fluorescence in the cytoplasm when a
region within the aggregate was bleached indicates the limited access of mCherry::ubiquitin to the Q82::GFP aggregates.
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are seen colocalizing to Q82::GFP aggregates in young
worms, the age in which aggregates begin appearing
(within 24 hours of hatching). Similar results are seen in
the ubiquitination of the Parkinson’s Disease protein
alpha-synuclein. In transfected cells, mutant alpha-synu-
clein that cannot be ubiquitinated can still form aggre-
gates, though the propensity for aggregation increases
when it is mono- or di-ubiquitinated [53].
A higher level of initial fluorescence is seen after
RNAi of ubc-22 a n di sa s s o c i a t e dw i t hah i g h e rr a t eo f
aggregation, both in the initial formation and the sec-
ondary growth phases. A higher level of Q82::GFP fluor-
escence may indicate a higher concentration of the
fusion protein in the area where the aggregate forms.
Thus, it is possible that UBC-22 normally functions in
the degradation of Q82::GFP. Eliminating its function
may allow Q82::GFP to accumulate, resulting in larger
aggregates formed from the increased quantity of intra-
cellular protein. E2-25K, the human homolog that is
most closely related to UBC-22 (32% identity), has been
s h o w nt ob ei n v o l v e di nt h ef o r m a t i o no fK 4 8 - l i n k e d
polyubiquitin chains [54] and to interact with the poly-
glutamine-containing protein huntingtin [55]. Since K48
chains are associated with proteasomal degradation, this
UBC may be involved in targeting aggregating proteins
for degradation.
The role of UBC-22 may be in localized or restricted
degradation of Q82:GFP since levels of GFP fluores-
cence levels measured in whole worms did not show dif-
ferences between control and ubc-22 RNAi (G.S, data
not shown). Thus, UBC-22 may have some role in pre-
venting the accumulation of Q82::GFP in specific
regions of the cell. Alternatively, UBC-22 may play a
role in setting the threshold for initial aggregation. As
cytosolic levels of Q82::GFP increase, molecular crowd-
ing can decrease the quality of the protein folding envir-
onment and increase the probability of polyglutamine
proteins adopting an aggregation-prone conformation.
RNAi of ubc-22 may increase the threshold concentra-
tion at which aggregates appear. A likely mechanism
that allows levels of polyglutamine protein to increase
locally without aggregating involves chaperones. It is
possible that UBC-22 normally inhibits chaperone activ-
ities, such as causing the ubiquitination and degradation
of chaperones.
UBC-22 is an atypical UBC in that the cysteine resi-
due (C74) near the putative catalytic domain is posi-
tioned 12 residues N-terminal to its expected position.
This positioning brings into question whether this UBC
is truly catalytically active. UBC-22 also appears to lack
some residues critical in binding ubiquitin in the UBC
domain. In Ubc1, the yeast ortholog of UBC-22, docking
analysis shows that residues L89-I91 and N119-P121
interact with ubiquitin when the C-terminus of ubiqui-
tin is placed at the active site cysteine residue of Ubc1
[56]. UBC-22 lacks corresponding residues. The same
analysis also revealed several residues (E117, D120, and
A111) in Ubc1 that appear to form hydrogen bonds
with ubiquitin. UBC-22 has closely corresponding resi-
dues (E101 and D110) for E117 and D120, but, unlike
E2-25K, lacks a residue corresponding to A111. Interest-
ingly, a yeast two-hybrid analysis showed that UBC-22
interacts with the RING finger E3 ligase NHL-1 [57].
Further experiments exploring the interaction of UBC-
22 and NHL-1 and their effects on aggregation may pro-
vide insight into the role of UBC-22.
Ubiquitin conjugating enzymes may affect aggregation
during the secondary growth phase
After the initial aggregation phase, polyglutamine aggre-
gates continue growth with a slower, secondary growth
phase. This secondary rate of growth is reduced by
RNAi of ubc-13 and to a lesser extent, uev-1.U B C - 1 3
and UEV-1 have been shown to interact in a yeast two-
h y b r i de x p e r i m e n t[ 5 8 ] ,S .U t a r r a l aa n dL . B . ,u n p u b -
lished data] and therefore may function as a dimer. In
yeast, this dimer is capable of catalyzing the formation
of K63-linked polyubiquitin chains. Since our current
study shows that K63 linked chains are present at poly-
glutamine aggregates, it is possible that proteins asso-
ciated with K63 ubiquitination may promote the
secondary growth of polyglutamine protein aggregates.
This mechanism may also explain the apparent disparity
between the relative sizes at the end of the initial aggre-
gate formation (Figure 2), and the beginning of the
observation of mature aggregates (Figure 3). As initial
formation was observed largely in L1 and L2 animals,
and mature aggregates observed in Figure 3 were largely
found in L2 and L3 animals, the secondary growth rates
during the intervening period can account for the
observed differences. Specifically, ubc-1 worms exhibit
the highest secondary growth rate (Table 2) and these
aggregates become comparable in size to the initially
larger ubc-22 aggregates over time. Also, ubc-13 worms
show the slowest secondaryg r o w t hr a t e( T a b l e2 )a n d
they then represent the smallest aggregate population
observed in the mature aggregate population (Figure 3).
We propose reduced K63-linked ubiquitination as a pos-
sible explanation for the lack of growth seen in ubc-13,
and, to a lesser extent, uev-1 RNAi-treated animals.
In other systems, it has been proposed that K63 ubi-
quitination of aggregating proteins leads to trafficking of
oligomers to aggregation sites [42]. It is unknown if this
same scenario exists in the C. elegans muscle. In mam-
mals, the adapter protein p62 has been implicated in
this trafficking process [38]. p62 contains a UBA domain
that is capable of binding to K63-linked
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mote aggregation in vivo and in vitro. C. elegans pos-
sesses a protein, SEPA-1, which, like p62, can recruit
specific proteins to the autophagy machinery for degra-
dation. However, it is unknown if SEPA-1 can bind
polyubiquitin chains [59]. An alternative hypothesis is
that K63-linked polyubiquitin chains may compete with
K48-linked chains for binding to the proteasome [60]. It
is possible that the reduction of K63-linked polyubiquiti-
nation in the cell might allow for increased degradation
of K48-linked polyubiquitinated proteins thus depleting
the cell of aggregation-prone proteins and lead to smal-
ler aggregates.
mCherry::ubiquitin localization to aggregates is highest
in the early L4 larval stage. This agrees with a time
course where major ubiquitination events occur after
initial aggregate formation. This accumulation of ubiqui-
tinated proteins may be related to general changes in
protein homeostasis that occur in C. elegans aging [61].
Alternatively, the late localization of ubiquitin to the
aggregates could be the result of increased proteasome
inhibition caused by protein aggregates. The results of
our study agree with observations by Stenoien, et al.
using a cotransfection assay of polyQ-expanded ataxin
fused to cyan fluorescent protein (CFP) and yellow
fluorescent protein fused to ubiquitin. They reported
that small aggregates of CFP-ataxin-84Q were typically
not ubiquitinated, while many larger aggregates con-
tained high levels of ubiquitin [62]. Treating the co-
transfected cells with the proteasome inhibitor MG132
resulted in accumulation of YFP-ubiquitin into aggre-
gates. In addition, there is some histological evidence to
suggest that ubiquitination of aggregates succeeds their
formation. Studies using huntingtin or ubiquitin-specific
antibodies to examine the brains from individuals suffer-
ing from varying clinical grades of HD found that ubi-
quitin was not present in all aggregates, and was present
in a higher percentage of aggregates in higher clinical
grades of the disease [63]. Animal studies found that in
a mouse model of the polyglutamine expansion disease
SCA7, the appearance of ubiquitin-positive aggregates
occurred no earlier than 12 weeks of age, which is up to
7 weeks later than the earliest detection of aggregates in
certain tissue [64].
Ubiquitin is mobile but sequestered within Q82::GFP
aggregates
In this study, both K48 and K63 ubiquitin chains were
detected in Q82::GFP aggregates. Similar to many pre-
vious reports, we observed that the antibody staining is
strongest in the periphery of the aggregates. The periph-
eral staining has prompted the question of whether that
pattern was a result of ubiquitin being restricted to the
periphery or whether the antibodies might be unable to
penetrate into the interior of the aggregate. In the Q82
+ Ub strain, many aggregates also show higher mCherry
fluorescence in the periphery (Figure 5A, B), supporting
the idea that ubiquitin is at a higher concentration at
the peripheral regions of the aggregate. A tempting
explanation for this is that ubiquitination is occuring on
aggregates after initial formation.
The FRAP results are also consistent with later
deposition of ubiquitinated proteins. Our results, like
previous FRAP studies of aggregated fluorescent fusion
proteins [45,48,65], show that there is little to no mobi-
lity of the aggregating species. Some aggregate asso-
ciated proteins are seen to be mobile or transiently
associated with aggregates, including chaperones [48],
CBP, proteasome subunits [62]. Similarly, the mCherry::
ubiquitin protein is largely mobile. The differences in
mobility between Q82::GFP and mCherry::ubiquitin indi-
cate that ubiquitin is not simply conjugated onto the
polyglutamine protein. It may be brought to aggregates
via its association with other proteins or it may exist in
aggregates as a ubiquitin monomer. Differences in the
conjugation state of the mCherry::Ub may also explain
the biphasic nature of the FRAP curve for this protein.
The rapid, initial recovery may be due to free mCherry::
Ub diffusing into the measurement area, while the
slower, secondary recovery may be occurring as ubiqui-
tin chains or larger ubiquitinated proteins diffuse into
this space. Alternatively, different topologies of mono-
or polyubiquitin moieties may have different binding
modes with respect to ubiquitin receptors sequestered
within the aggregate, thus providing varying diffusion
kinetics within this environment.
Interestingly, examination of the Q82::GFP aggregates
using FLIP shows that mCherry::ubiquitin within the
aggregates does not exchange significantly with the cyto-
plasm. This sequestration of ubiquitin into aggregates
may indicate a high concentration of ubiquitin receptors
within the aggregate. In accordance with this, cell based
assays using polyQ-expanded ataxin found that aggre-
gates of this protein contain ubiquitin binding structures
including PUB motifs, ubiquitin-interacting motifs
(UIMs), and ubiquitin-associated (UBA) domains [66].
Ubiquitinated proteins may be recruited to aggregates
via binding to these domains. Of course, this prompts
the question of how these ubiquitin binding proteins are
recruited to aggregates. The proteasome, which contains
both chaperone-like subunits and ubiquitin binding
domains [67], may be the source of ubiquitin attracting
activity in aggregates. Proteasomes may initially localize
to aggregates via affinity for misfolded proteins. If pro-
teasomes become engaged in failed attempts to unfold
and degrade polyglutamine fibrils, this may lead to the
accumulation of ubiquitinated substrates in the cyto-
plasm. Finally, accumulation of proteasomes at
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ubiquitin to the aggregates in our model. In support of
this, our previous RNAi screen indicated that RNAi
treatments that significantly reduce the size of aggre-
gates also eliminated ubiquitin immunoreactivity in the
aggregates, and RNAi of ubiquitin itself resulted in
smaller Q82::GFP aggregates [17]. Another possible
explanation for the seemingly different mobilities seen
between the FRAP and FLIP studies of the mCherry::Ub
protein within the aggregate is that the aggregates have
subcompartments or are formed from multiple smaller
aggregates. If this is the case, then it could be expected
that bleaching an area of the aggregate will result in a
quick recovery of fluorescence in the bleach area (as in
the FRAP results), without reducing fluorescence in a
separate part of the aggregate by exchanging mobile
protein.
Conclusion
These studies provide insight into the role of ubiquitina-
tion in a nematode model of polyglutamine protein
aggregation. Time-lapse analyses of aggregate formation
indicate an initial phase of growth that is likely sponta-
neous and not directly dependent upon ubiquitin. RNAi
of ubc-22 affects the initial aggregation rate by increas-
ing intracellular levels of soluble Q82::GFP fusion pro-
tein. Secondary growth is slower and appears to be
more affected by ubiquitination. There is a period dur-
ing the fourth larval stage in which ubiquitin is maxi-
mally located to Q82::GFP aggregates. Ubiquitin appears
to be mobile, but sequestered within aggregates. These
results suggest a model in which polyglutamine proteins
misfold and rapidly form small aggregates, which subse-
quently attract substrates that have been ubiquitinated
by a variety of E2 and E3 enzymes. The development of
therapies for diseases involving loss of protein quality
control may benefit from understanding how ubiquitina-
tion is involved in the handling of misfolded, damaged,
or aggregating proteins.
Methods
Worm strains and maintenance
The Q82::GFP strain was created by Satyal et al. [47]
and subsequently converted to integrated strain UA4
[49]. The LN139 strain harboring an integrated plasmid
expressing the mCherry::ubiquitin fusion protein in
muscle cells was created via microparticle bombardment
with a plasmid created using the multisite Gateway sys-
tem (Invitrogen). Entry plasmids for the unc-54 promo-
ter, the unc-54 3’ UTR, and the destination vector,
pCR319, were gifts from Chris Ritchie. The entry plas-
mid with the mCherry::ubiquitin open reading frame
was created by fusing mCherry to the N-terminus of
ubiquitin in the pDONR221 vector. The LN149 strain
(Q82 + Ub) was created by crossing the UA4 strain with
LN139.
The temperature sensitive uba-1 strain (RV110) was
obtained from Harold Smith and carries the it129 allele
of uba-1 [50]. Males of this strain were crossed with the
UA4 strain. A line showing 100% lethality at the non-
permissive temperature and stably expressing the Q82::
GFP transgene in the body wall muscle cells was propa-
gated and used for the current study (LN150). Aggre-
g a t e si nt h eL N 1 5 0s t r a i nd on o tb e g i nf o r m i n gi n
significant numbers until approximately 24 hours after
egg laying.
Worm strains were maintained according to standard
methods [68]. Briefly, worms were cultured on nema-
tode growth medium with E. coli strain OP50 and
stored at 20°C, 16°C, or 25°C and 50 percent humidity.
Worms for experimentation were chunked repeatedly
from a stock plate containing starved worms. OP50 and
HT115 E. coli strains were obtained from the Caenor-
habditis Genetics Center.
Nematode RNAi
RNAi feeding clones and procedures were previously
described [17]. Petri plates containing 4.0 mL of NGM
agar were supplemented with IPTG (Isopropyl b-D-1-
thiogalactopyranoside) and ampicillin to achieve concen-
trations of 1 mM and 0.1 mg/mL, respectively. Plates
were seeded with 125 μL of overnight HT115 culture
and allowed to dry. L2 larval worms were transferred to
RNAi plates and allowed to mature and lay eggs. L1 and
L2 progeny were used for time-lapse observations. For
RNAi treatment of Q82 + Ub worms in time course
experiments, NGM plates containing 0.5% lactose and
100 mg/mL ampicillin were used to induce dsRNA pro-
duction in HT115 bacteria.
Microscopy and Time-lapse Analysis
Worms were washed from RNAi plates using M9 buffer
and gravity sedimented for 5 minutes to pellet adults.
Supernatants containing early larvae were pelleted by
further gravity sedimentation (20 minutes) and washed
3X in M9 buffer to remove bacteria. Larvae were col-
lected in a 15 μL drop of M9 and transferred to the cen-
ter of a dried agarose pad on a glass microscope slide.
Slides were mounted by applying a thin ring of petro-
leum jelly and placing a #1 coverslip over the ring.
Worms were illuminated continuously using a Nikon
E600 epifluorescence microscope equipped with a 100-
watt mercury lamp. A Nikon 10X objective was used in
conjunction with the 2X optivar (200X total magnifica-
tion). Neutral density filters (#16 and #8) were placed in
the light path to reduce illumination intensity. Images
were captured continuously (1 minute per exposure)
using a Qicam 1394 Cooled-CCD monochrome camera,
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netics) software was used to capture and process images.
Newly-formed aggregates were manually identified in
the time-lapse imaging series. The total pixel intensity
(on a scale of 0 to 4095) was measured over time in
square regions of interest where aggregates appeared.
Only singular, laterally stationary aggregates forming in
L1 and L2 worms were recorded. Aggregates were
imaged for 240 minutes. Data presented in Figure 3
begins at 30 minutes after the start of the observation
period.
For time-lapse imaging of Q82::GFP in uba-1 mutants,
worms were grown at the permissive temperature, 16°C.
When plates were enriched with laid eggs, larvae and
adult worms were washed from the plates, leaving only
eggs. Plates with eggs were shifted to the non-permissive
25°C temperature. After 24 hours, hatched larvae were
washed from plates and subjected to time-lapse micro-
scopy as described above.
To observe secondary growth of preformed aggregates,
the aggregates existing at the beginning of the time-
lapse observation period were measured over time. The
Track Objects feature in Image Pro Plus 6.1 was used to
automatically find and measure the intensity of these
objects. Aggregates overlapping in the Z axis or in close
proximity to other aggregates were omitted.
To measure mCherry::ubiquitin colocalization to Q82::
GFP aggregates, images were taken using a 40X lens, at
multiple Z planes first for mCherry, then for GFP. Z-
stacks were pseudocolored and merged to form 48-bit
color z-stacks. The line profile measurement tool in
Image Pro 6.1 was used to measure GFP and mCherry
fluorescence across the center diameter of Q82::GFP
aggregates
Photobleaching experiments
All photobleaching experiments were performed using
a Zeiss LSM710 laser scanning confocal system
coupled to a Zeiss AxioObserver equipped with a 40X
1.2NA water-immersion lens. LN149 worms were
chunked from stock plates and incubated for 72-hours.
L4-stage and adult worms were mounted on slides in
M9 containing 5 mg/mL tetramisole as described for
time-lapse analysis. For FRAP, aggregates of interest in
adult worms were viewed at a zoom level of 22.0, with
a frame size of 51.8 μm
2. Fluorescence was bleached to
approximately 50% of initial intensity. Images were
acquired every 100 ms using bidirectional scanning
with a 555 nm laser (for mCherry) or 488 nm laser
(for GFP) set to 0.5% power. 100 pre-bleach images
were acquired prior to bleaching. Bleaching was direc-
ted to an area near the periphery of the Q82::GFP
aggregates in a rectangular area of 0.79 μm
2 using the
555 nm laser at 100% power for 3 iterations or the 488
nm laser at 100% power for 1 iteration. A second,
non-bleached region measured within the same aggre-
gate was used to control for acquisition photobleach-
ing. Mobile fraction (Mf) was calculated from FRAP
data using the equation Mf =( I f-I1)/(I0-I1), where If is
the final fluorescence intensity in the bleached region
after recovery, I1 is the mean fluorescence intensity
immediately after bleaching, and I0 is the fluorescence
intensity prior to bleaching.
For FLIP, worms were viewed at a zoom level of 8.0,
with a frame size of 396.0 μm
2. Images were acquired
every 3 seconds using unidirectional scanning. After 6
prebleach images were acquired, repeated bleaching was
directed at a square area of 0.81 μm
2 every 7 seconds
using a 555 nm laser set to 100% and running for 10
iterations per bleach. Separate experiments were per-
formed in which bleaches were directed to regions
within the aggregate or the cytoplasm, and fluorescence
measurements were collected for non-bleached regions
within both the aggregate and the cytoplasm. To control
for acquisition photobleaching, fluorescence was mea-
sured in separate cell that was not subject to FLIP. Rela-
tive fluorescence intensity was calculated using the
following formula (It/Nt)/(I0/N0), where It is the mean
fluorescence intensity in the region of interest at a given
time point, Nt is the fluorescence intensity at non-
bleached control region at a given time point, I0 is the
initial (pre-bleach) mean fluorescence intensity in the
region of interest, and N0 is the initial mean fluores-
cence intensity in a non-bleached control region.
Immunofluorescence
Gravid Q82::GFP worms were age synchronized by
treating gravid adults with hypochlorite solution to
extract embryos. These progeny were allowed to hatch
on a standard NGM plate and grow for 72 hours. Adult
worms were then washed from the plates, washed 3X in
M9 buffer, and once in distilled water. Concentrated
worms were placed on a polylysine-coated slide and fro-
z e ni nl i q u i dn i t r o g e n .T h ec overslip was removed and
w o r m sw e r ef i x e do nt h es l i d e su s i n g- 2 0 ° Cm e t h a n o l
for 20 minutes. After several washes in PBS, slides were
blocked for 30 minutes using normal goat serum.
Worms were then incubated for 2 hours with the pri-
mary antibody (diluted 1:200) specific for K48 (Millipore
clone Apu2) or K63-linked (Millipore clone Apu3) poly-
ubiquitin chains. The secondary antibody (diluted 1:200)
was rhodamine-conjugated goat anti-rabbit IgG (Jackson
ImmunoResearch). Worms were imaged using a 40X
lens. Images were collected at multiple Z-planes first for
TRITC, then for Q82::GFP. Images were generated by
flattening Z-stacks into composite extended depth-of-
field images, which were pseudocolored and merged to
view colocalization.
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Additional file 1: Video 1 This video shows a transgenic C. elegans
larva expressing Q82::GFP fusion protein. Several aggregates are
formed during the course of filming. One hour of real time elapses in
this video, and each frame represents 1 minute of real time. Brightness
and contrast of the green-pseudocolored GFP fluorescence channel have
been increased from the original images to show the diffuse, soluble
material. A single DIC image is repeated for every frame and serves as an
anatomical reference. The brightness and contrast have been adjusted
for the DIC image to enhance visualization of the GFP channel. A 10X
lens with a 2X optvar was used, to give 200X total magnification. Video
plays at 10 frames/sec with each frame representing one minute of
recording time.
Additional file 2: Video 2 This video shows aggregation prone
fluorescent Q82::GFP fusion protein expressed in the body wall
muscle cells of a transgenic C. elegans larva. An aggregate is seen
forming in the lower right of the image. The video represents 40
minutes of real time. Video plays at 10 frames/sec, with each frame
representing one minute of recording time. A 10X lens with a 2X optvar
was used, to give 200X total magnification. Brightness and contrast were
increased to better show the diffuse, soluble material. Scale bar indicates
a distance of 10 microns.
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